Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-034453
Filing Date
2024-08-30
Accepted
2024-08-29 21:07:37
Documents
35
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 460613
2 ex31-1.htm EX-31.1 17560
3 ex31-2.htm EX-31.2 17518
4 ex32-1.htm EX-32.1 6681
  Complete submission text file 0001493152-24-034453.txt   1825653

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE anav-20240331.xsd EX-101.SCH 11727
6 XBRL CALCULATION FILE anav-20240331_cal.xml EX-101.CAL 19782
7 XBRL DEFINITION FILE anav-20240331_def.xml EX-101.DEF 39498
8 XBRL LABEL FILE anav-20240331_lab.xml EX-101.LAB 117829
9 XBRL PRESENTATION FILE anav-20240331_pre.xml EX-101.PRE 95636
37 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 149463
Mailing Address 11801 PIERCE ST., 2ND FLOOR RIVERSIDE CA 92505
Business Address 11801 PIERCE ST., 2ND FLOOR RIVERSIDE CA 92505 951-530-1862
ALPHA NETWORK ALLIANCE VENTURES INC. (Filer) CIK: 0001491829 (see all company filings)

EIN.: 451649826 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54126 | Film No.: 241265596
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)